<?xml version="1.0" encoding="UTF-8"?><xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:g="http://xbrl.dcca.dk/sob" xmlns:b="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature" xmlns:h="http://xbrl.dcca.dk/mrv" xmlns:f="http://xbrl.dcca.dk/arr" xmlns:d="http://xbrl.dcca.dk/cmn" xmlns:e="http://xbrl.dcca.dk/fsa" xmlns:c="http://xbrl.dcca.dk/gsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature http://archprod.service.eogs.dk/taxonomy/20161001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20161001.xsd"><link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/20161001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20161001.xsd"/><c:InformationOnTypeOfSubmittedReport contextRef="c11">Årsrapport</c:InformationOnTypeOfSubmittedReport><c:IdentificationNumberCvrOfSubmittingEnterprise contextRef="c11">28939523</c:IdentificationNumberCvrOfSubmittingEnterprise><c:NameOfSubmittingEnterprise contextRef="c11">ECOVIS Danmark</c:NameOfSubmittingEnterprise><c:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="c11">Nørregade 6B</c:AddressOfSubmittingEnterpriseStreetAndNumber><c:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="c11">4100 Ringsted</c:AddressOfSubmittingEnterprisePostcodeAndTown><c:ReportingPeriodStartDate contextRef="c11">2016-04-01</c:ReportingPeriodStartDate><c:ReportingPeriodEndDate contextRef="c11">2017-03-31</c:ReportingPeriodEndDate><c:PrecedingReportingPeriodStartDate contextRef="c11">2015-04-01</c:PrecedingReportingPeriodStartDate><c:PredingReportingPeriodEndDate contextRef="c11">2016-03-31</c:PredingReportingPeriodEndDate><c:DateOfApprovalOfReport contextRef="c11">2017-05-23</c:DateOfApprovalOfReport><c:IdentificationNumberCvrOfReportingEntity contextRef="c11">10132029</c:IdentificationNumberCvrOfReportingEntity><c:NameOfReportingEntity contextRef="c11">Ecron Acunova A/S</c:NameOfReportingEntity><c:AddressOfReportingEntityStreetName contextRef="c11">Venlighedsvej</c:AddressOfReportingEntityStreetName><c:AddressOfReportingEntityStreetBuildingIdentifier contextRef="c11">6</c:AddressOfReportingEntityStreetBuildingIdentifier><c:AddressOfReportingEntityPostCodeIdentifier contextRef="c11">2970</c:AddressOfReportingEntityPostCodeIdentifier><c:AddressOfReportingEntityDistrictName contextRef="c11">Hørsholm</c:AddressOfReportingEntityDistrictName><c:AddressOfReportingEntityCountryIdentificationCode contextRef="c11">DK</c:AddressOfReportingEntityCountryIdentificationCode><c:AddressOfReportingEntityCountry contextRef="c11">Danmark</c:AddressOfReportingEntityCountry><c:RegisteredOfficeOfReportingEntity contextRef="c11">Rudersdal</c:RegisteredOfficeOfReportingEntity><c:NameOfFinancialInstitution contextRef="c11">Nordea</c:NameOfFinancialInstitution><d:NameOfAuditFirm contextRef="c12">Ecovis Danmark</d:NameOfAuditFirm><d:IdentificationNumberCvrOfAuditFirm contextRef="c12">28939523</d:IdentificationNumberCvrOfAuditFirm><d:NameAndSurnameOfAuditor contextRef="c12">Kurt Bülow</d:NameAndSurnameOfAuditor><d:DescriptionOfAuditor contextRef="c12">Statsautoriseret revisor</d:DescriptionOfAuditor><c:AddressOfAuditorStreetName contextRef="c12">St. Kongensgade</c:AddressOfAuditorStreetName><c:AddressOfAuditorStreetBuildingIdentifier contextRef="c12">36, 3.th</c:AddressOfAuditorStreetBuildingIdentifier><c:AddressOfAuditorPostCodeIdentifier contextRef="c12">1264</c:AddressOfAuditorPostCodeIdentifier><c:AddressOfAuditorDistrictName contextRef="c12">København K</c:AddressOfAuditorDistrictName><c:AddressOfAuditorCountryIdentificationCode contextRef="c12">DK</c:AddressOfAuditorCountryIdentificationCode><c:AddressOfAuditorCountry contextRef="c11">Danmark</c:AddressOfAuditorCountry><c:TelephoneNumberOfAuditor contextRef="c12">57 61 45 40</c:TelephoneNumberOfAuditor><c:DateOfGeneralMeeting contextRef="c11">2017-06-30</c:DateOfGeneralMeeting><c:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="c11">Lalit Kanta Mahapatra</c:NameAndSurnameOfChairmanOfGeneralMeeting><e:ClassOfReportingEntity contextRef="c11">Regnskabsklasse B</e:ClassOfReportingEntity><e:SelectedElementsFromReportingClassC contextRef="c11">true</e:SelectedElementsFromReportingClassC><d:TypeOfAuditorAssistance contextRef="c11">Revisionspåtegning</d:TypeOfAuditorAssistance><d:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c104">Martinus Theodorus Boom</d:NameAndSurnameOfMemberOfExecutiveBoard><d:TitleOfMemberOfExecutiveBoard contextRef="c104">adm. direktør</d:TitleOfMemberOfExecutiveBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c89">Lalit Kantra Mahapatra</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:TitleOfMemberOfSupervisoryBoard contextRef="c89" xml:lang="da">formand</d:TitleOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c90">Ashokkumar Nagarajan</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c91">Priya Jebarani Aldam</d:NameAndSurnameOfMemberOfSupervisoryBoard><f:SignatureOfAuditorsPlace contextRef="c11">København</f:SignatureOfAuditorsPlace><f:SignatureOfAuditorsDate contextRef="c11">2017-05-23</f:SignatureOfAuditorsDate><d:NameOfAuditFirm contextRef="c12">Ecovis Danmark</d:NameOfAuditFirm><d:NameAndSurnameOfAuditor contextRef="c12">Kurt Bülow</d:NameAndSurnameOfAuditor><d:DescriptionOfAuditor contextRef="c12">Statsautoriseret revisor</d:DescriptionOfAuditor><e:GrossProfitLoss contextRef="c11" unitRef="u3" decimals="0">2985609</e:GrossProfitLoss><e:GrossProfitLoss contextRef="c58" unitRef="u3" decimals="0">4678093</e:GrossProfitLoss><e:EmployeeBenefitsExpense contextRef="c11" unitRef="u3" decimals="0">4029111</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c58" unitRef="u3" decimals="0">4155080</e:EmployeeBenefitsExpense><e:IncomeFromInvestmentsInGroupEnterprises contextRef="c11" unitRef="u3" decimals="0">-411064</e:IncomeFromInvestmentsInGroupEnterprises><e:IncomeFromInvestmentsInGroupEnterprises contextRef="c58" unitRef="u3" decimals="0">-752025</e:IncomeFromInvestmentsInGroupEnterprises><e:OtherFinanceIncome contextRef="c11" unitRef="u3" decimals="0">5369</e:OtherFinanceIncome><e:OtherFinanceIncome contextRef="c58" unitRef="u3" decimals="0">36587</e:OtherFinanceIncome><e:OtherFinanceExpenses contextRef="c11" unitRef="u3" decimals="0">43858</e:OtherFinanceExpenses><e:OtherFinanceExpenses contextRef="c58" unitRef="u3" decimals="0">38312</e:OtherFinanceExpenses><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c11" unitRef="u3" decimals="0">-1493055</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c58" unitRef="u3" decimals="0">-230737</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:TaxExpense contextRef="c11" unitRef="u3" decimals="0">0</e:TaxExpense><e:TaxExpense contextRef="c58" unitRef="u3" decimals="0">0</e:TaxExpense><e:ProfitLoss contextRef="c11" unitRef="u3" decimals="0">-1493055</e:ProfitLoss><e:ProfitLoss contextRef="c58" unitRef="u3" decimals="0">-230737</e:ProfitLoss><e:ProfitLoss contextRef="c72" unitRef="u3" decimals="0">-1493055</e:ProfitLoss><e:ProfitLoss contextRef="c73" unitRef="u3" decimals="0">-230737</e:ProfitLoss><e:FixturesFittingsToolsAndEquipment contextRef="c75" unitRef="u3" decimals="0">0</e:FixturesFittingsToolsAndEquipment><e:FixturesFittingsToolsAndEquipment contextRef="c74" unitRef="u3" decimals="0">0</e:FixturesFittingsToolsAndEquipment><e:PropertyPlantAndEquipment contextRef="c75" unitRef="u3" decimals="0">0</e:PropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c74" unitRef="u3" decimals="0">0</e:PropertyPlantAndEquipment><e:LongtermInvestmentsInGroupEnterprises contextRef="c75" unitRef="u3" decimals="0">499746</e:LongtermInvestmentsInGroupEnterprises><e:LongtermInvestmentsInGroupEnterprises contextRef="c74" unitRef="u3" decimals="0">963324</e:LongtermInvestmentsInGroupEnterprises><e:OtherLongtermReceivables contextRef="c75" unitRef="u3" decimals="0">142227</e:OtherLongtermReceivables><e:OtherLongtermReceivables contextRef="c74" unitRef="u3" decimals="0">215712</e:OtherLongtermReceivables><e:ContributedCapitalInArrearsLongTerm contextRef="c75" unitRef="u3" decimals="0">0</e:ContributedCapitalInArrearsLongTerm><e:ContributedCapitalInArrearsLongTerm contextRef="c74" unitRef="u3" decimals="0">0</e:ContributedCapitalInArrearsLongTerm><e:LongtermInvestmentsAndReceivables contextRef="c75" unitRef="u3" decimals="0">641973</e:LongtermInvestmentsAndReceivables><e:LongtermInvestmentsAndReceivables contextRef="c74" unitRef="u3" decimals="0">1179036</e:LongtermInvestmentsAndReceivables><e:NoncurrentAssets contextRef="c75" unitRef="u3" decimals="0">641973</e:NoncurrentAssets><e:NoncurrentAssets contextRef="c74" unitRef="u3" decimals="0">1179036</e:NoncurrentAssets><e:ShorttermTradeReceivables contextRef="c75" unitRef="u3" decimals="0">656816</e:ShorttermTradeReceivables><e:ShorttermTradeReceivables contextRef="c74" unitRef="u3" decimals="0">2694110</e:ShorttermTradeReceivables><e:ShorttermReceivablesFromGroupEnterprises contextRef="c75" unitRef="u3" decimals="0">94853</e:ShorttermReceivablesFromGroupEnterprises><e:ShorttermReceivablesFromGroupEnterprises contextRef="c74" unitRef="u3" decimals="0">646371</e:ShorttermReceivablesFromGroupEnterprises><e:OtherShorttermReceivables contextRef="c75" unitRef="u3" decimals="0">153618</e:OtherShorttermReceivables><e:OtherShorttermReceivables contextRef="c74" unitRef="u3" decimals="0">93598</e:OtherShorttermReceivables><e:CurrentDeferredTaxAssets contextRef="c75" unitRef="u3" decimals="0">500000</e:CurrentDeferredTaxAssets><e:CurrentDeferredTaxAssets contextRef="c74" unitRef="u3" decimals="0">500000</e:CurrentDeferredTaxAssets><e:DeferredIncomeAssets contextRef="c75" unitRef="u3" decimals="0">72590</e:DeferredIncomeAssets><e:DeferredIncomeAssets contextRef="c74" unitRef="u3" decimals="0">91872</e:DeferredIncomeAssets><e:ShorttermReceivables contextRef="c75" unitRef="u3" decimals="0">1477877</e:ShorttermReceivables><e:ShorttermReceivables contextRef="c74" unitRef="u3" decimals="0">4025951</e:ShorttermReceivables><e:CashAndCashEquivalents contextRef="c75" unitRef="u3" decimals="0">533438</e:CashAndCashEquivalents><e:CashAndCashEquivalents contextRef="c74" unitRef="u3" decimals="0">2205524</e:CashAndCashEquivalents><e:CurrentAssets contextRef="c75" unitRef="u3" decimals="0">2011315</e:CurrentAssets><e:CurrentAssets contextRef="c74" unitRef="u3" decimals="0">6231475</e:CurrentAssets><e:Assets contextRef="c75" unitRef="u3" decimals="0">2653288</e:Assets><e:Assets contextRef="c74" unitRef="u3" decimals="0">7410511</e:Assets><e:ContributedCapital contextRef="c75" unitRef="u3" decimals="0">4497000</e:ContributedCapital><e:ContributedCapital contextRef="c74" unitRef="u3" decimals="0">4497000</e:ContributedCapital><e:ReserveForNetRevaluationAccordingToEquityMethod contextRef="c75" unitRef="u3" decimals="0">499746</e:ReserveForNetRevaluationAccordingToEquityMethod><e:ReserveForNetRevaluationAccordingToEquityMethod contextRef="c74" unitRef="u3" decimals="0">963324</e:ReserveForNetRevaluationAccordingToEquityMethod><e:RetainedEarnings contextRef="c75" unitRef="u3" decimals="0">-4231409</e:RetainedEarnings><e:RetainedEarnings contextRef="c74" unitRef="u3" decimals="0">-3201932</e:RetainedEarnings><e:Equity contextRef="c75" unitRef="u3" decimals="0">765337</e:Equity><e:Equity contextRef="c74" unitRef="u3" decimals="0">2258392</e:Equity><e:ShorttermTradePayables contextRef="c75" unitRef="u3" decimals="0">1476576</e:ShorttermTradePayables><e:ShorttermTradePayables contextRef="c74" unitRef="u3" decimals="0">457521</e:ShorttermTradePayables><e:ShorttermPrepaymentsOfWorkInProgress contextRef="c75" unitRef="u3" decimals="0">0</e:ShorttermPrepaymentsOfWorkInProgress><e:ShorttermPrepaymentsOfWorkInProgress contextRef="c74" unitRef="u3" decimals="0">2339827</e:ShorttermPrepaymentsOfWorkInProgress><e:ShorttermPayablesToGroupEnterprises contextRef="c75" unitRef="u3" decimals="0">0</e:ShorttermPayablesToGroupEnterprises><e:ShorttermPayablesToGroupEnterprises contextRef="c74" unitRef="u3" decimals="0">1972683</e:ShorttermPayablesToGroupEnterprises><e:OtherShorttermPayables contextRef="c75" unitRef="u3" decimals="0">411375</e:OtherShorttermPayables><e:OtherShorttermPayables contextRef="c74" unitRef="u3" decimals="0">382088</e:OtherShorttermPayables><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c75" unitRef="u3" decimals="0">1887951</e:ShorttermLiabilitiesOtherThanProvisions><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c74" unitRef="u3" decimals="0">5152119</e:ShorttermLiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c75" unitRef="u3" decimals="0">1887951</e:LiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c74" unitRef="u3" decimals="0">5152119</e:LiabilitiesOtherThanProvisions><e:LiabilitiesAndEquity contextRef="c75" unitRef="u3" decimals="0">2653288</e:LiabilitiesAndEquity><e:LiabilitiesAndEquity contextRef="c74" unitRef="u3" decimals="0">7410511</e:LiabilitiesAndEquity><e:WagesAndSalaries contextRef="c11" unitRef="u3" decimals="0">3459972</e:WagesAndSalaries><e:WagesAndSalaries contextRef="c58" unitRef="u3" decimals="0">3711802</e:WagesAndSalaries><e:PostemploymentBenefitExpense contextRef="c11" unitRef="u3" decimals="0">267704</e:PostemploymentBenefitExpense><e:PostemploymentBenefitExpense contextRef="c58" unitRef="u3" decimals="0">221973</e:PostemploymentBenefitExpense><e:SocialSecurityContributions contextRef="c11" unitRef="u3" decimals="0">134734</e:SocialSecurityContributions><e:SocialSecurityContributions contextRef="c58" unitRef="u3" decimals="0">25964</e:SocialSecurityContributions><e:OtherEmployeeExpense contextRef="c11" unitRef="u3" decimals="0">166701</e:OtherEmployeeExpense><e:OtherEmployeeExpense contextRef="c58" unitRef="u3" decimals="0">195341</e:OtherEmployeeExpense><e:EmployeeBenefitsExpense contextRef="c11" unitRef="u3" decimals="0">4029111</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c58" unitRef="u3" decimals="0">4155080</e:EmployeeBenefitsExpense><e:AverageNumberOfEmployees contextRef="c11" unitRef="u4" decimals="INF">5</e:AverageNumberOfEmployees><e:AverageNumberOfEmployees contextRef="c58" unitRef="u4" decimals="INF">6</e:AverageNumberOfEmployees><e:PropertyPlantAndEquipmentGross contextRef="c211" unitRef="u3" decimals="0">100000</e:PropertyPlantAndEquipmentGross><e:PropertyPlantAndEquipmentGross contextRef="c213" unitRef="u3" decimals="0">100000</e:PropertyPlantAndEquipmentGross><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c211" unitRef="u3" decimals="0">100000</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c213" unitRef="u3" decimals="0">-100000</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c213" unitRef="u3" decimals="0">0</e:PropertyPlantAndEquipment><e:InvestmentsGross contextRef="c76" unitRef="u3" decimals="0">7</e:InvestmentsGross><e:InvestmentsGross contextRef="c77" unitRef="u3" decimals="0">7</e:InvestmentsGross><e:InvestmentsGross contextRef="c80" unitRef="u3" decimals="0">7</e:InvestmentsGross><e:InvestmentsGross contextRef="c81" unitRef="u3" decimals="0">7</e:InvestmentsGross><e:AccumulatedRevaluationsOfInvestments contextRef="c76" unitRef="u3" decimals="0">963317</e:AccumulatedRevaluationsOfInvestments><e:AccumulatedRevaluationsOfInvestments contextRef="c77" unitRef="u3" decimals="0">1715342</e:AccumulatedRevaluationsOfInvestments><e:IncreaseDecreaseOfRevaluationsAndDevaluationsOfInvestmentsThroughNetExchangeDifferences contextRef="c78" unitRef="u3" decimals="0">-52514</e:IncreaseDecreaseOfRevaluationsAndDevaluationsOfInvestmentsThroughNetExchangeDifferences><e:IncreaseDecreaseOfRevaluationsAndDevaluationsOfInvestmentsThroughNetExchangeDifferences contextRef="c79" unitRef="u3" decimals="0">10826</e:IncreaseDecreaseOfRevaluationsAndDevaluationsOfInvestmentsThroughNetExchangeDifferences><e:ProfitLossRelatedToInvestments contextRef="c78" unitRef="u3" decimals="0">-411064</e:ProfitLossRelatedToInvestments><e:ProfitLossRelatedToInvestments contextRef="c79" unitRef="u3" decimals="0">-762851</e:ProfitLossRelatedToInvestments><e:AccumulatedRevaluationsOfInvestments contextRef="c80" unitRef="u3" decimals="0">499739</e:AccumulatedRevaluationsOfInvestments><e:AccumulatedRevaluationsOfInvestments contextRef="c81" unitRef="u3" decimals="0">963317</e:AccumulatedRevaluationsOfInvestments><e:LongtermInvestmentsAndReceivables contextRef="c80" unitRef="u3" decimals="0">499746</e:LongtermInvestmentsAndReceivables><e:LongtermInvestmentsAndReceivables contextRef="c81" unitRef="u3" decimals="0">963324</e:LongtermInvestmentsAndReceivables><e:RelatedEntityName contextRef="c454">Ecron Acunova Pte Ltd</e:RelatedEntityName><e:RelatedEntityRegisteredOffice contextRef="c454">Singapore</e:RelatedEntityRegisteredOffice><e:ShareHeldByEntityOrConsolidatedEnterprisesInRelatedEntity contextRef="c455" unitRef="u4" decimals="1">100</e:ShareHeldByEntityOrConsolidatedEnterprisesInRelatedEntity><e:Equity contextRef="c455" unitRef="u3" decimals="INF">499746</e:Equity><e:ProfitLoss contextRef="c454" unitRef="u3" decimals="INF">-411064</e:ProfitLoss><e:ContractWorkInProgressGross contextRef="c75" unitRef="u3" decimals="0">0</e:ContractWorkInProgressGross><e:ContractWorkInProgressGross contextRef="c74" unitRef="u3" decimals="0">0</e:ContractWorkInProgressGross><e:AdvanceInvoicingContractWorkInProgress contextRef="c11" unitRef="u3" decimals="0">0</e:AdvanceInvoicingContractWorkInProgress><e:AdvanceInvoicingContractWorkInProgress contextRef="c58" unitRef="u3" decimals="0">2339827</e:AdvanceInvoicingContractWorkInProgress><e:Equity contextRef="c113" unitRef="u3" decimals="0">4497000</e:Equity><e:Equity contextRef="c125" unitRef="u3" decimals="0">963324</e:Equity><e:Equity contextRef="c131" unitRef="u3" decimals="0">-3201932</e:Equity><e:ProfitLoss contextRef="c127" unitRef="u3" decimals="0">0</e:ProfitLoss><e:ProfitLoss contextRef="c132" unitRef="u3" decimals="0">-1493055</e:ProfitLoss><e:ProfitLlossFromGroupEnterprises contextRef="c127" unitRef="u3" decimals="0">-463578</e:ProfitLlossFromGroupEnterprises><e:ProfitLlossFromGroupEnterprises contextRef="c132" unitRef="u3" decimals="0">463578</e:ProfitLlossFromGroupEnterprises><e:Equity contextRef="c115" unitRef="u3" decimals="0">4497000</e:Equity><e:Equity contextRef="c126" unitRef="u3" decimals="0">499746</e:Equity><e:Equity contextRef="c133" unitRef="u3" decimals="0">-4231409</e:Equity><e:NumberOfIssuedShares contextRef="c226" unitRef="u1" decimals="INF">8994</e:NumberOfIssuedShares><e:NominalValueOfIssuedShares contextRef="c226" unitRef="u3" decimals="0">4497000</e:NominalValueOfIssuedShares><g:IdentificationOfApprovedAnnualReport contextRef="c11">Bestyrelsen og direktionen har dags dato behandlet og godkendt årsrapporten for regnskabsåret 1. april 2016 - 31. marts 2017 for Ecron Acunova A/S.
The supervisory and executive boards have today discussed and approved the annual report of Ecron Acunova A/S for the financial year 1 April 2016 - 31 March 2017.</g:IdentificationOfApprovedAnnualReport><g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c11">Årsrapporten aflægges i overensstemmelse med årsregnskabsloven.
The annual report is prepared in accordance with the Danish Financial Statements Act.</g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement><g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c11">Det er vores opfattelse, at årsregnskabet giver et retvisende billede af selskabets aktiver, passiver og finansielle stilling pr. 31. marts 2017 og resultatet af selskabets aktiviteter for regnskabsåret 1. april 2016 - 31. marts 2017.
In our opinion, the financial statements give a true and fair view of the company's financial position at 31 March 2017 and of the results of the company's operations for the financial year 1 April 2016 - 31 March 2017.</g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults><g:ManagementsStatementAboutManagementsReview contextRef="c11">Ledelsesberetningen indeholder efter vores opfattelse en retvisende redegørelse for de forhold, beretningen omhandler.
In our opinion, management's review includes a fair review of the matters dealt with in the management's review.</g:ManagementsStatementAboutManagementsReview><g:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c11">Årsrapporten indstilles til generalforsamlingens godkendelse.
Management recommends that the annual report should be approved at the annual general meeting.</g:RecommendationForApprovalOfAnnualReportByGeneralMeeting><f:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="c11">Til kapitalejeren i Ecron Acunova A/S
To the shareholder of Ecron Acunova A/S</f:AddresseeOfAuditorsReportOnAuditedFinancialStatements><f:OpinionOnAuditedFinancialStatements contextRef="c11">Vi har revideret årsregnskabet for Ecron Acunova A/S for regnskabsåret 1. april 2016 - 31. marts 2017, der omfatter resultatopgørelse, balance, noter og anvendt regnskabspraksis. Årsregnskabet udarbejdes efter årsregnskabsloven.
We have audited the financial statements of Ecron Acunova A/S for the financial year 1 April 2016 - 31 March 2017, which comprise  income statement, balance sheet, notes and summary of significant accounting policies. The financial statements are prepared under the Danish Financial Statements Act.
Det er vor opfattelse, at årsregnskabet giver et retvisende billede af selskabets aktiver, passiver og finansielle stilling pr. 31. marts 2017 samt af resultatet af selskabets aktiviteter for regnskabsåret 1. april 2016 - 31. marts 2017 i overensstemmelse med årsregnskabsloven.
In our opinion, the financial statements give a true and fair view of the company's financial position at 31 marts 2017 and of the results of the company's operations for the financial year 1 April 2016 - 31 March 2017 in accordance with the Danish Financial Statements Act.</f:OpinionOnAuditedFinancialStatements><f:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="c11">Vi har udført vor revision i overensstemmelse med internationale standarder om revision og de yderligere krav, der er gældende i Danmark. Vort ansvar ifølge disse standarder og krav er nærmere beskrevet i revisionspåtegningens afsnit “Revisors ansvar for revisionen af årsregnskabet“. Vi er uafhængige af selskabet i overensstemmelse med internationale etiske regler for revisorer (IESBA’s Etiske regler) og de yderligere krav, der er gældende i Danmark, ligesom vi har opfyldt vor øvrige etiske forpligtelser i henhold til disse regler og krav. Det er vor opfattelse, at det opnåede revisionsbevis er tilstrækkeligt og egnet som grundlag for vor konklusion.
We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor's responsibilities for the audit of the financial statements” section of our report. We are independent of the company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.</f:DescriptionOfQualificationsOfAuditedFinancialStatements><f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="c11">Ledelsen har ansvaret for udarbejdelsen af et årsregnskab, der giver et retvisende billede i overensstemmelse med årsregnskabsloven. Ledelsen har endvidere ansvaret for den interne kontrol, som ledelsen anser for nødvendig for at udarbejde et årsregnskab uden væsentlig fejlinformation, uanset om denne skyldes besvigelser eller fejl.
Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act, and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
Ved udarbejdelsen af årsregnskabet er ledelsen ansvarlig for at vurdere selskabets evne til at fortsætte driften, at oplyse om forhold vedrørende fortsat drift, hvor dette er relevant, samt at udarbejde årsregnskabet på grundlag af regnskabsprincippet om fortsat drift, medmindre ledelsen enten har til hensigt at likvidere selskabet, indstille driften eller ikke har andet realistisk alternativ end at gøre dette.
In preparing the financial statements, management is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the financial statements unless management either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so.</f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements><f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="c11">Vort mål er at opnå høj grad af sikkerhed for, om årsregnskabet som helhed er uden væsentlig fejlinformation, uanset om denne skyldes besvigelser eller fejl, og at afgive en revisionspåtegning med en konklusion. Høj grad af sikkerhed er et højt niveau af sikkerhed, men er ikke en garanti for, at en revision, der udføres i overensstemmelse med internationale standarder om revision og de yderligere krav, der er gældende i Danmark, altid vil afdække væsentlig fejlinformation, når sådan findes. Fejlinformationer kan opstå som følge af besvigelser eller fejl og kan betragtes som væsentlige, hvis det med rimelighed kan forventes, at de enkeltvis eller samlet har indflydelse på de økonomiske beslutninger, som regnskabsbrugerne træffer på grundlag af årsregnskabet.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements
Som led i en revision, der udføres i overensstemmelse med internationale standarder om revision og de yderligere krav, der er gældende i Danmark, foretager vi faglige vurderinger og opretholder professionel skepsis under revisionen. Herudover:
As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
Identificerer og vurderer vi risikoen for væsentlig fejlinformation i årsregnskabet, uanset om denne skyldes besvigelser eller fejl, udformer og udfører revisionshandlinger som reaktion på disse risici samt opnår revisionsbevis, der er tilstrækkeligt og egnet til at danne grundlag for vor konklusion. Risikoen for ikke at opdage væsentlig fejlinformation forårsaget af besvigelser er højere end ved væsentlig fejlinformation forårsaget af fejl, idet besvigelser kan omfatte sammensværgelser, dokumentfalsk, bevidste udeladelser, vildledning eller tilsidesættelse af intern kontrol.
Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Opnår vi forståelse af den interne kontrol med relevans for revisionen for at kunne udforme revisionshandlinger, der er passende efter omstændighederne, men ikke for at kunne udtrykke en konklusion om effektiviteten af selskabets interne kontrol.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company's internal control.
Tager vi stilling til, om den regnskabspraksis, som er anvendt af ledelsen, er passende, samt om de regnskabsmæssige skøn og tilknyttede oplysninger, som ledelsen har udarbejdet, er rimelige.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
Konkluderer vi, om ledelsens udarbejdelse af årsregnskabet på grundlag af regnskabsprincippet om fortsat drift er passende, samt om der på grundlag af det opnåede revisionsbevis er væsentlig usikkerhed forbundet med begivenheder eller forhold, der kan skabe betydelig tvivl om selskabets evne til at fortsætte driften. Hvis vi konkluderer, at der er en væsentlig usikkerhed, skal vi i vor revisionspåtegning gøre opmærksom på oplysninger herom i årsregnskabet eller, hvis sådanne oplysninger ikke er tilstrækkelige, modificere vor konklusion. Vor konklusioner er baseret på det revisionsbevis, der er opnået frem til datoen for vor revisionspåtegning. Fremtidige begivenheder eller forhold kan dog medføre, at selskabet ikke længere kan fortsætte driften.
Conclude on the appropriateness of management's use of the going concern basis of accounting in preparing the financial statements and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.
Tager vi stilling til den samlede præsentation, struktur og indhold af årsregnskabet, herunder noteoplysningerne, samt om årsregnskabet afspejler de underliggende transaktioner og begivenheder på en sådan måde, at der gives et retvisende billede heraf.
Evaluate the overall presentation, structure and contents of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that gives a true and fair view.
Vi kommunikerer med den øverste ledelse om blandt andet det planlagte omfang og den tidsmæssige placering af revisionen samt betydelige revisionsmæssige observationer, herunder eventuelle betydelige mangler i intern kontrol, som vi identificerer under revisionen.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.</f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed><f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="c11">Udtalelse om ledelsesberetningen
Statement on management's review
Ledelsen er ansvarlig for ledelsesberetningen.
Management is responsible for management's review.
Vor konklusion om årsregnskabet omfatter ikke ledelsesberetningen, og vi udtrykker ingen form for konklusion med sikkerhed om ledelsesberetningen.
Our opinion on the financial statements does not cover management's review, and we do not express any form of assurance conclusion thereon.
I tilknytning til vor revision af årsregnskabet er det vort ansvar at læse ledelsesberetningen og i den forbindelse overveje, om ledelsesberetningen er væsentligt inkonsistent med årsregnskabet eller vor viden opnået ved revisionen eller på anden måde synes at indeholde væsentlig fejlinformation.
In connection with our audit of the financial statements, our responsibility is to read management's review and, in doing so, consider whether management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Vort ansvar er derudover at overveje, om ledelsesberetningen indeholder krævede oplysninger i henhold til årsregnskabsloven.
Moreover, it is our responsibility to consider whether management's review provides the information required under the Danish Financial Statements Act.
Baseret på det udførte arbejde er det vor opfattelse, at ledelsesberetningen er i overensstemmelse med årsregnskabet og er udarbejdet i overensstemmelse med årsregnskabslovens krav. Vi har ikke fundet væsentlig fejlinformation i ledelsesberetningen.
Based on the work we have performed, we conclude that management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of management's review.</f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements><h:ManagementsReview contextRef="c11">Selskabets væsentligste aktiviteter
Business activities
Selskabets væsentligste funktion er at Ecron Acunova A/S (datterselskab af Ecron Acunova GmbH) er en Contract Research Organisation, der inden for udvikling af lægemidler tilbyder en bred vifte af services til investorer, produkudviklere og selskaber, der er banebrydende i branchen og som står stærkt i den Nordiske region. Selskabet medvirker til at krav om at komme på markedet hurtigt og effektivt opfyldes. Selskabet fungerer tillige som en strategisk partner for lokal pharmacuetisk, biotech- og medicinsk udstyrsindustri med klinisk udvikling, der medvirker til at opfylde deres mål og fremtidige krav til klinisk dokumentation. Den brede vifte af services indenfor udvikling af lægemidler og medicinsk udstyr ledes af højt uddannede og motiverede medarbejdere.
Ecron Acunova A/S (Subsidiary of Ecron Acunova GmbH) is a Contract Research Organisation wich offers a full range of services for medicinal product development to investors, product developers and entrepreneurial companies, and has a presence in the Nordic are. Ecron Acunova meets the need of its clients for getting their medicinal products to the market fast and efficiently. The company works as a strategic partner for the local pharmaceutical, biotech and medical device industry in clinical development, contributing to fulfillment of their goals and future demands for clinical documentation. The wide range of services within medicine and medical devicedevelopment is managed by highly qualified and motivated employees.</h:ManagementsReview><e:DisclosureOfIncomeIncludingDividendIncomeFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c11">Andel af overskud i tilknyttede virksomheder 
-411.064
-752.025
Share of profits of subsidiaries 


 
-411.064
-752.025</e:DisclosureOfIncomeIncludingDividendIncomeFromInvestmentsInGroupEnterprisesAndAssociates><e:DisclosureOfTaxExpenseOnOrdinaryActivities contextRef="c11">Skat af årets resultat fordeles således:
Tax on profit/loss for the year is calculated as follows:
Beregnet  skat af årets resultat før skat
-328.472
-54.223
Calculated  tax on profit/loss for the year before tax



Skatteeffekt af:
Tax effect of:
Skat ikke fradragsberettigede omkostninger og ikke skattepligtige indtægter
527.646
439.253
Tax on non-deductible expenses and non-taxable income


Regulering af skat vedrørende tidligere år
-199.174
-385.030
Adjustment of tax concerning previous years



0
0</e:DisclosureOfTaxExpenseOnOrdinaryActivities><e:DisclosureOfContingentLiabilities contextRef="c11">Selskabets lejemål kan opsiges med 10 måneders varsel. Den samlede ydelse i perioden udgør ca. TDKK 347.
The company's lease can be terminated with ten months notice. Total payments in the remaining period amoun to approx TDKK 347.
</e:DisclosureOfContingentLiabilities><e:DisclosureOfMortgagesAndCollaterals contextRef="c11">Selskabet har et tinglyst skadeløsbrev på t.kr. 3.000 med pant i nuværende og fremtidige erhvervelser af driftsinventar og driftsmateriel efter reglerne om virksomhedspant (flydende pant). Pr. 31/3 2016 er pantet ikke stillet til sikkerhed over for nogen gæld. 
The company has a registered mortgage deed for a limited amount of T.DKK 3,000 secured on current and future acquisitions of operating equipment and fixtures according to the rules of corporate mortgage (floating charge). As of 31/3 2016 the mortgage are not pledget as security for any debt.
</e:DisclosureOfMortgagesAndCollaterals><e:InformationOnRelatedEntities contextRef="c11">10
Nærtstående parter og ejerforhold

Related parties and ownership
Bestemmende indflydelse
Controlling interest
Ecron Acunova GmbH  Tyskland
Parent company

Ejerforhold
Ownership
Følgende kapitalejer er noteret i selskabets ejerbog som ejende minimum 5% af stemmerne eller minimum 5% af selskabskapitalen:
According to the Company's register of shareholders, the following shareholders hold a minimum of 5% of the voting rights or a minimum of 5% of the share capital:

Ecron Acunova GmbH, Tyskland (Germany)
</e:InformationOnRelatedEntities><e:InformationOnReportingClassOfEntity contextRef="c11">Årsrapporten for Ecron Acunova A/S for 2016/17 er aflagt i overensstemmelse med årsregnskabslovens bestemmelser for virksomheder i regnskabsklasse B med tilvalg fra højere klasser.
The annual report of Ecron Acunova A/S for 2016/17 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B as well as selected provisions as regards larger entities.
Den anvendte regnskabspraksis er uændret i forhold til sidste år.
The accounting policies applied are consistent with those of last year.
Årsrapporten for 2016/17 er aflagt i kr.
The annual report for 2016/17 is presented in kr.
Selskabet har i henhold til årsregnskabslovens §110, stk. 1 undladt at udarbejde koncernregnskab.
Pursuant to sections §110 subsection 1, of the Danish Financial Statements Act, the company has not prepared consolidated financial statements.</e:InformationOnReportingClassOfEntity><e:InformationOnOmissionOfConsolidatedFinancialStatement contextRef="c11">Selskabet har i henhold til årsregnskabslovens §110, stk. 1 undladt at udarbejde koncernregnskab.
Pursuant to sections §110 subsection 1, of the Danish Financial Statements Act, the company has not prepared consolidated financial statements.</e:InformationOnOmissionOfConsolidatedFinancialStatement><e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies contextRef="c11">I resultatopgørelsen indregnes indtægter i takt med, at de indtjenes. Herudover indregnes værdireguleringer af finansielle aktiver og forpligtelser. I resultatopgørelsen indregnes ligeledes alle omkostninger, herunder afskrivninger og nedskrivninger. 
Income is recognised in the income statement as earned, including value adjustments of financial assets and liabilities. All expenses, including amortisation, depreciation and impairment losses, are also recognised in the income statement.
Aktiver indregnes i balancen, når det er sandsynligt, at fremtidige økonomiske fordele vil tilflyde selskabet, og aktivets værdi kan måles pålideligt.
Assets are recognised in the balance sheet when it is probable that future economic benefits will flow to the company's and the value of the asset can be measured reliably.
Forpligtelser indregnes i balancen, når det er sandsynligt, at fremtidige økonomiske fordele vil fragå selskabet, og forpligtelsens værdi kan måles pålideligt.
Liabilities are recognised in the balance sheet when it is probable that future economic benefits will flow from the company's and the value of the liability can be measured reliably.
Ved første indregning måles aktiver og forpligtelser til kostpris. Efterfølgende måles aktiver og forpligtelser som beskrevet for hver enkelt regnskabspost nedenfor.
On initial recognition, assets and liabilities are measured at cost. On subsequent recognition, assets and liabilities are measured as described below for each individual accounting item.
Visse finansielle aktiver og forpligtelser måles til amortiseret kostpris, hvorved der indregnes en konstant effektiv rente over løbetiden. Amortiseret kostpris opgøres som oprindelig kostpris med fradrag af eventuelle afdrag samt tillæg/fradrag af den akkumulerede amortisering af forskellen mellem kostpris og nominelt beløb. 
Certain financial assets and liabilities are measured at amortised cost using the effective interest method. Amortised cost is calculated as the historic cost less any instalments and plus/less the accumulated amortisation of the difference between the cost and the nominal amount. 
Ved indregning og måling tages hensyn til forudsigelige tab og risici, der fremkommer, inden årsrapporten aflægges, og som be- eller afkræfter forhold, der eksisterede på balancedagen.
On recognition and measurement, allowance is made for predictable losses and risks which occur before the annual report are presented and which confirm or invalidate matters existing at the balance sheet date.</e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss contextRef="c11">Selskabet anvender bestemmelsen i årsregnskabslovens § 32, hvorefter selskabets omsætning ikke er oplyst.
In pursuance of section 32 of the Danish Financial Statements Act, the company does not disclose its revenue. 
Bruttofortjeneste er et sammendrag af nettoomsætning, ændring i lagre af færdigvarer og varer under fremstilling samt andre driftsindtægter med fradrag af omkostninger til råvarer og hjælpematerialer og andre eksterne omkostninger.
Gross profit reflects an aggregation of revenue, changes in inventories of finished goods and work in progress and other operating income less raw materials and consumables and other external expenses.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c11">Indtægter indregnes i resultatopgørelsen, når levering og risikoovergang til køber har fundet sted, og hvis indtægten kan opgøres pålideligt og forventes modtaget.
Income is recognised in the income statement, provided that the transfer of risk, usually on delivery to the buyer, has taken place and that the income can be measured reliably and is expected to be received.
Nettoomsætningen måles til dagsværdien af det aftalte vederlag ekskl. moms og afgifter. Alle former for afgivne rabatter er fratrukket i nettoomsætningen.
Revenue is measured at the fair value of the agreed consideration, excluding VAT and other indirect taxes. Revenue is net of all types of discounts granted.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c11">Andre eksterne omkostninger omfatter omkostninger til distribution, salg, reklame, administration, lokaler, tab på debitorer mv.
Other external costs, specifikation include expenses related to distribution, sale, advertising, administration, premises, bad debts etc.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c11">Personaleomkostninger omfatter løn og gager, inklusive feriepenge og pensioner samt andre omkostninger til social sikring m.v. til selskabets medarbejdere. I personaleomkostninger er fratrukket modtagne godtgørelser fra offentlige myndigheder.
Staff costs include wages and salaries, including compensated absence and pensions, as well as other social security contributions, etc. made to the entity's employees. The item is net of refunds made by public authorities.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c11">Finansielle indtægter og omkostninger indregnes i resultatopgørelsen med de beløb, der vedrører regnskabsåret. Finansielle poster omfatter renteindtægter og -omkostninger, finansielle omkostninger ved finansiel leasing, realiserede og urealiserede kursgevinster og -tab vedrørende værdipapirer, gæld og transaktioner i fremmed valuta, amortisering af realkreditlån samt tillæg og godtgørelse under acontoskatteordningen mv.
Financial income and expenses are recognised in the income statement at the amounts relating to the financial year. Net financials include interest income and expenses, financial expenses relating to finance leases, realised and unrealised capital/exchange gains and losses on securities and foreign currency transactions, amortisation of mortgage loans and surcharges and allowances under the advance-payment-of-tax scheme, etc.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c11">I virksomhedens resultatopgørelse indregnes den forholdsmæssige andel af de enkelte dattervirksomheders resultat efter skat efter fuld eliminering af intern avance/tab.
The proportionate share of the results after tax of the individual subsidiaries is recognised in the income statement of the companyafter full elimination of intra-group profits/losses.
I virksomhedens resultatopgørelse indregnes den forholdsmæssige andel af de associerede virksomheders resultat efter skat efter eliminering af forholdsmæssig andel af intern avance/tab.
The proportionate share of the results after tax of the associates is recognised in the company income statement after elimination of the proportionate share of intra-group profits/gains.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c11">Årets skat, som består af årets aktuelle selskabsskat og ændring i udskudt skat, indregnes i resultatopgørelsen med den del, der kan henføres til årets resultat, og direkte i egenkapitalen med den del, der kan henføres til posteringer direkte i egenkapitalen.
Tax for the year, which comprises the current tax charge for the year and changes in the deferred tax charge, including changes arising from changes in tax rates, is recognised in the income statement as regards the portion that relates to entries directly in equity.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c11">Andre anlæg, driftsmateriel og inventar måles til kostpris med fradrag af akkumulerede af- og nedskrivninger.
Items of Land and buildings, plant and machinery and fixtures and fittings, tools and equipment are measured at cost less accumulated depreciation and impairment losses.
Afskrivningsgrundlaget er kostpris med fradrag af forventet restværdi efter afsluttet brugstid. Der afskrives ikke på grunde.
The depreciable amount is cost less the expected residual value at the end of the useful life. Land is not depreciated.
Kostpris omfatter anskaffelsesprisen og omkostninger direkte tilknyttet anskaffelsen indtil det tidspunkt, hvor aktivet er klar til brug. For egne fremstillede aktiver omfatter kostprisen direkte og indirekte omkostninger til materialer, komponenter, underleverandører og løn.
Cost comprises the purchase price and any costs directly attributable to the acquisition until the date when the asset is available for use. The cost of self-constructed assets comprises direct and indirect costs of materials, components, sub-suppliers and wages.
Der foretages lineære afskrivninger baseret på følgende vurdering af aktivernes forventede brugstider og restværdier:
Straight-line depreciation is provided on the basis of the following estimated useful lives of the assets:
Brugstid Restværdi
Useful life Residual value 
Andre anlæg, driftsmateriel og inventar  5  år 0 %
Other fixtures and fittings, tools and equipment  5  years 0 %

Aktiver med en kostpris på under kr. 12.900 omkostningsføres i anskaffelsesåret.
Assets costing less than kr. 12.900 are expensed in the year of acquisition.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment><e:InformationOnLeasingContracts contextRef="c11">Alle leasingkontrakter er operationel leasing. Ydelser i forbindelse med operationel leasing og øvrige lejeaftaler indregnes i resultatopgørelsen over kontraktens løbetid. Selskabets samlede forpligtelse vedrørende operationelle leasing- og lejeaftaler oplyses under eventualposter mv.
All  leases are operating leases. Payments relating to operating leases and any other leases are recognised in the income statement over the term of the lease. The company's total liabilities relating to operating leases and other rent agreements are disclosed under 'Contingencies, etc.'.</e:InformationOnLeasingContracts><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates contextRef="c11">Kapitalandele i dattervirksomheder og associerede virksomheder måles til den forholdsmæssige andel af virksomhedernes indre værdi opgjort efter koncernens regnskabspraksis med fradrag eller tillæg af urealiserede koncerninterne avancer og tab og med tillæg eller fradrag af resterende værdi af positiv eller negativ goodwill opgjort efter overtagelsesmetoden.
Investments in subsidiaries and associates are measured at the proportionate share of the net asset value of the entities, calculated on the basis of the group's accounting policies, less or plus unrealised intra-group gains or losses and plus or less any remaining value of positive or negative goodwill made up according to the purchase method.
Kapitalandele i dattervirksomheder og associerede virksomheder med regnskabsmæssig negativ indre værdi måles til kr. 0, og et eventuelt tilgodehavende hos disse virksomheder nedskrives, i det omfang tilgodehavendet er uerholdeligt. I det omfang modervirksomheden har en retlig eller faktisk forpligtelse til at dække en underbalance, der overstiger tilgodehavendet, indregnes det resterende beløb under hensatte forpligtelser.
Investments in subsidiaries and associates with a negative net asset value are measured at DKK 0, and the carrying amount of any receivables from these entities is reduced to the extent that they are considered irrecoverable. If the parent company has a legal or constructive obligation to cover a deficit that exceeds the receivable, the balance is recognised under provisions.
Nettoopskrivning af kapitalandele i dattervirksomheder og associerede virksomheder bindes som reserve for nettoopskrivning efter den indre værdis metode under egenkapitalen, i det omfang den regnskabsmæssige værdi overstiger kostprisen. Udbytter fra dattervirksomheder, der forventes vedtaget inden godkendelsen af årsrapporten for Ecron Acunova A/S, bindes ikke på opskrivningsreserven.
Net revaluations of investments in subsidiaries and associates are taken to the net revaluation reserve according to the equity method to the extent that the carrying amount exceeds the cost. Dividends from subsidiaries which are expected to be declared before the annual report of  Ecron Acunova A/S is adopted are not taken to the net revaluation reserve.
Ved køb af virksomheder anvendes overtagelsesmetoden, jf. beskrivelse ovenfor under opgørelse af goodwill. 
Acquisitions are accounted for using the purchase method, cf. the description of the statement of goodwill above.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c11">Tilgodehavender måles til amortiseret kostpris.
Receivables are measured at amortised cost.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfContractWorkInProgress contextRef="c11">Igangværende arbejder for fremmed regning måles til salgsværdien af det udførte arbejde. Salgsværdien måles på baggrund af færdiggørelsesgraden på balancedagen og de samlede forventede indtægter på det enkelte igangværende arbejde. Færdiggørelsesgraden opgøres som andelen af de afholdte omkostninger i forhold til forventede samlede omkostninger på det enkelte igangværende arbejde.
Contract work in progress is measured at the selling price of the work performed. The selling price is measured based on the stage of completion at the balance sheet date and the expected aggregate income from the individual work in progress. The stage of completion is determined as the share of the expenses incurred relative to the expected total expenses for the individual work in progress.
Når salgsværdien på et enkelt igangværende arbejde ikke kan opgøres pålideligt, måles salgsværdien til de medgåede omkostninger eller nettorealisationsværdien, hvis denne er lavere.
Where the selling price of work in progress cannot be reliably determined, the selling price is measured at the lower of costs incurred and net realisable value.
Det enkelte igangværende arbejde indregnes i balancen under tilgodehavender eller gældsforpligtelser. Nettoaktiver udgøres af summen af de igangværende arbejder, hvor salgsværdien af det udførte arbejde overstiger acontofaktureringer. Nettoforpligtelser udgøres af summen af de igangværende arbejder, hvor acontofaktureringer overstiger salgsværdien.
The individual work in progress is recognised in the balance sheet under receivables or payables. Net assets comprise the sum of work in progress where the selling price of the work performed exceeds invoicing on account. Net liabilities comprise the sum of work in progress where invoicing on account exceeds the selling price.
Omkostninger i forbindelse med salgsarbejde og opnåelse af kontrakter indregnes i resultatopgørelsen i takt med, at de afholdes.
Selling costs and costs incurred in securing contracts are recognised in the income statement as incurred.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfContractWorkInProgress><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets contextRef="c11">Periodeafgrænsningsposter, indregnet under omsætningsaktiver, omfatter afholdte omkostninger vedrørende efterfølgende regnskabsår.
Prepayments comprise costs incurred concerning subsequent financial years.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c11">Aktuelle skatteforpligtelser og tilgodehavende aktuel skat indregnes i balancen som beregnet skat af årets skattepligtige indkomst reguleret for skat af tidligere års skattepligtige indkomster samt for betalte acontoskatter.
Current tax obligations and  receivable tax is recognized in the balance sheet as calculated tax on profit/loss for the year, regulated tax from previous years, and account payments.
Udskudt skat måles efter den balanceorienterede gældsmetode af midlertidige forskelle mellem regnskabsmæssig og skattemæssig værdi af aktiver og forpligtelser, opgjort på grundlag af den planlagte anvendelse af aktivet, henholdsvis afvikling af forpligtelsen.
Deferred income tax is measured using the balance sheet liability method in respect of temporary differences arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes on the basis of the intended use of the asset and settlement of the liability, respectively.
Udskudte skatteaktiver, herunder skatteværdien af fremførselsberettiget skattemæssigt underskud, måles til den værdi, hvortil aktivet forventes at kunne realiseres, enten ved udligning i skat af fremtidig indtjening eller ved modregning i udskudte skatteforpligtelser. 
Deferred tax assets, including the tax base of tax loss carry-forwards, are measured at the value at which the asset is expected to be realised, either by elimination in tax on future earnings or by set-off against deferred tax liabilities.
Udskudt skat måles på grundlag af de skatteregler og skattesatser, der med balancedagens lovgivning vil være gældende, når den udskudte skat forventes udløst som aktuel skat. I de tilfælde, hvor opgørelse af skatteværdien kan foretages efter alternative beskatningsregler, måles udskudt skat på grundlag af den planlagte anvendelse af aktivet, henholdsvis afvikling af forpligtelsen.
Ændring i udskudt skat indregnes i resultatopgørelsen. 
Deferred tax is measured on the basis of the tax rules and tax rates that will be effective under the legislation at the balance sheet date when the deferred tax is expected to crystallise as current tax. In cases where the computation of the tax base may be made according to alternative tax rules, deferred tax is measured on the basis of the intended use of the asset and settlement of the liability, respectively.
Any changes in deferred tax are recognised in the income statement. </e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c11">Gældsforpligtelser, som omfatter gæld til leverandører, tilknyttede virksomheder samt anden gæld, måles til amortiseret kostpris, hvilket sædvanligvis svarer til nominel værdi.
Liabilities, which include trade receivables, payables to group entities and other payables, are measured at amortised cost, which is usually equivalent to nominal value.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions><e:DescriptionOfMethodsOfForeignCurrencies contextRef="c11">Transaktioner i fremmed valuta omregnes ved første indregning til transaktionsdagens kurs. Valutakursdifferencer, der opstår mellem transaktionsdagens kurs og kursen på betalingsdagen, indregnes i resultatopgørelsen som en finansiel post. Hvis valutapositioner anses for sikring af fremtidige pengestrømme, indregnes værdireguleringerne direkte på egenkapitalen.
On initial recognition, foreign currency transactions are translated applying the exchange rate at the transaction date. Foreign-exchange differences arising between the exchange rates at the transaction date and at the date of payment are recognised in the income statement as financial income or financial expenses. If foreign currency transactions are considered cash flow hedges, the value adjustments are taken directly to equity.
Tilgodehavender, gæld og andre monetære poster i fremmed valuta omregnes til balancedagens valutakurs. Forskellen mellem balancedagens kurs og kursen på tidspunktet for tilgodehavendets eller gældsforpligtelsens opståen eller indregning i seneste årsregnskab indregnes i resultatopgørelsen under finansielle indtægter og omkostninger. 
Receivables and payables and other monetary items denominated in foreign currencies are translated at the exchange rates at the balance sheet date. The difference between the exchange rates at the balance sheet date and the date at which the receivable or payable arose or was recognised in the latest financial statements is recognised in the income statement as financial income or financial expenses. 
Udenlandske dattervirksomheder og associerede virksomheder anses for at være selvstændige enheder. Resultatopgørelserne omregnes til en gennemsnitlig valutakurs for måneden, og balanceposterne omregnes til balancedagens valutakurser. Kursdifferencer, opstået ved omregning af udenlandske dattervirksomheders egenkapital ved årets begyndelse til balancedagens valutakurser og ved omregning af resultatopgørelser fra gennemsnitskurser til balancedagens valutakurser, indregnes direkte i egenkapitalen.
Foreign group entities and associates are considered separate entities. The income statements are translated at the average exchange rates for the month, and the balance sheet items are translated at the exchange rates at the balance sheet date. Foreign exchange differences arising on translation of the opening balance of equity of such entities at the exchange rates at the balance sheet date and on translation of the income statements from the exchange rates at the transaction date to the exchange rates at the balance sheet date are taken directly to equity.
Kursregulering af mellemværender med selvstændige udenlandske dattervirksomheder, der anses for en del af den samlede investering i dattervirksomheden, indregnes direkte i egenkapitalen. Tilsvarende indregnes valutakursgevinster og -tab på lån og afledte finansielle instrumenter indgået til sikring af nettoinvestering i udenlandske dattervirksomheder direkte i egenkapitalen.
Foreign exchange adjustments of balances with unrelated foreign subsidiaries which are considered part of the investment in the subsidiary are taken directly to equity. Correspondingly, foreign exchange gains and losses on loans and derivative financial instruments hedging separate foreign subsidiaries are taken directly to equity.</e:DescriptionOfMethodsOfForeignCurrencies><!--Aktuelle periode enkelt selskab--><context id="c11"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period></context><!--REVISOR1--><context id="c12"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfAuditorDimension"><d:auditorIdentifier>1</d:auditorIdentifier></xbrldi:typedMember></scenario></context><!--Forrige periode enkelt selskab--><context id="c58"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2015-04-01</startDate><endDate>2016-03-31</endDate></period></context><!--Overfoert resultat aktuel i aaret--><context id="c72"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfoert resultat forrige i aaret--><context id="c73"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2015-04-01</startDate><endDate>2016-03-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Slutdato forrige periode enkelt selskab--><context id="c74"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2016-03-31</instant></period></context><!--Slutdato aktuelle periode enkelt selskab--><context id="c75"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2017-03-31</instant></period></context><!--Kapandele tilknyttede aktuel primo--><context id="c76"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2016-04-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede forrige primo--><context id="c77"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2015-04-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede aktuel i aaret--><context id="c78"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede forrige i aaret--><context id="c79"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2015-04-01</startDate><endDate>2016-03-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede aktuel ultimo--><context id="c80"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2017-03-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede forrige ultimo--><context id="c81"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2016-03-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--BOARD1--><context id="c89"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD2--><context id="c90"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>2</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD3--><context id="c91"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>3</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--CEO1--><context id="c104"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfExecutiveBoardDimension"><d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--Virksomhedskapital aktuel primo--><context id="c113"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2016-04-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel ultimo--><context id="c115"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2017-03-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Reserve for nettoopskrivning indre vardi aktuel primo--><context id="c125"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2016-04-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForNetRevaluationAccordingToEquityMethodMember</xbrldi:explicitMember></scenario></context><!--Reserve for nettoopskrivning indre vardi aktuel ultimo--><context id="c126"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2017-03-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForNetRevaluationAccordingToEquityMethodMember</xbrldi:explicitMember></scenario></context><!--Reserve for nettoopskrivning indre vardi aktuel i aaret--><context id="c127"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForNetRevaluationAccordingToEquityMethodMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel primo--><context id="c131"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2016-04-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel i aaret--><context id="c132"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel ultimo--><context id="c133"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2017-03-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel primo--><context id="c211"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2016-04-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel ultimo--><context id="c213"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2017-03-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Aktiespec1--><context id="c226"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2017-03-31</instant></period><scenario><xbrldi:typedMember dimension="e:IdentificationOfClassOfSharesDimension"><e:classOfSharesIdentifier>1</e:classOfSharesIdentifier></xbrldi:typedMember></scenario></context><!--Datterselskab1--><context id="c454"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><startDate>2016-04-01</startDate><endDate>2017-03-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:TypeOfRelatedEntityDimension">e:SubsidiaryMember</xbrldi:explicitMember><xbrldi:typedMember dimension="e:IdentificationOfRelatedEntityDimension"><e:relatedEntityIdentifier>1</e:relatedEntityIdentifier></xbrldi:typedMember></scenario></context><!--Datterselskab ultimo1--><context id="c455"><entity><identifier scheme="http://www.dcca.dk/cvr">10132029</identifier></entity><period><instant>2017-03-31</instant></period><scenario><xbrldi:explicitMember dimension="e:TypeOfRelatedEntityDimension">e:SubsidiaryMember</xbrldi:explicitMember><xbrldi:typedMember dimension="e:IdentificationOfRelatedEntityDimension"><e:relatedEntityIdentifier>1</e:relatedEntityIdentifier></xbrldi:typedMember></scenario></context><!--Aktier--><unit id="u1"><measure>xbrli:shares</measure></unit><!--DKK enere--><unit id="u3"><measure>iso4217:DKK</measure></unit><!--Antal--><unit id="u4"><measure>xbrli:pure</measure></unit></xbrl>